| 000 | 00960 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511214433.0 | ||
| 264 | 0 | _c19900713 | |
| 008 | 199007s 0 0 eng d | ||
| 022 | _a0085-5928 | ||
| 024 | 7 |
_a10.3109/00365529009091915 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrimblecombe, R | |
| 245 | 0 | 0 |
_aMesalazine: a global safety evaluation. _h[electronic resource] |
| 260 |
_bScandinavian journal of gastroenterology. Supplement _c1990 |
||
| 300 |
_a66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAminosalicylic Acids _xadverse effects |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMesalamine |
| 650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
| 773 | 0 |
_tScandinavian journal of gastroenterology. Supplement _gvol. 172 _gp. 66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/00365529009091915 _zAvailable from publisher's website |
| 999 |
_c1978482 _d1978482 |
||